[1] Prakash A,Lamb HM.Mizolastine,a review of its use in allergic rhinitis and chronic idiopathic urticaria.Biodrug,1998,10:42-59.
[2] Scadding GK,Tasman AJ,Murrieta-Aguttes M,et al.Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis riperex study group.J Int Med Res,1999,27:273-285.
[3] Simons FE.Mizolastine,antihistaminic activity from preclinical data to clinical evaluation.Clin Exp Allergy,1999,29(Suppl 1):1-3.
[4] Danjou P,Molinier P,Berlin I,et al.Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects.Br J Clin Pharmacol,1992,34:328-331.
[5] Rosenzweig P,Thebault JJ,Caplain H,et al.Pharmacodynamics and pharmacokinetics of mizolastine (SL-85.0324),a new nonsedative H1 antihistamine.Ann Allergy,1992,69:135-139.
[6] Wedi B,Novacovic V,Koerner M,et al.Chronic urticaria serum induces histamine release,leukotriene production,and basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs.J Allergy Clin Immunol,2000,105:552-560.
[7] Pichat P,Angel I,Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.Arzneimittelforschung,1998,48:173-178.
[8] Simons FE,Simons KJ.Clinical pharmacology of new histamine H1 receptor antagonists.Clin Pharmacokinet,1999,36:329-352.
[9] Slater JW,Zechnich AD,Haxby DG.Second-generation antihistamines,a comparative review.Drugs,1999,57:31-47.
[10] Pinquier JL,Caplain H,Cabanis MJ,et al.Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine.J Clin Pharmacol,1996,36:72-78.
[11] Leynadier F,Duarte-Risselin C,Murrieta M,et al.Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria.URTILOR study group.Eur J Dermatol,2000,10:205-211.
[12] Dubertret L,Murrieta Aguttes M,Tonet J,et al.Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria,results of the MILOR study.J Eur Acad Dermatol Venereol,1999,12:16-24.
[13] Bousquet J.Rapid symptom relief in rhinitis.Clin Exp Allergy,1999,29(Suppl 1):25-29.
[14] Scadding GK,Tasman AJ,Murrieta-Aguttes M,et al.Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis.riperex study group.J Int Med Res,1999,27:273-285.
[15] Bellioni P,Catalano B,Cervellera G,et al.Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.Rhinology,1996,34:101-104.
[16] Mattila MJ,Paakkari H.Variations among non-sedating antihistamines,are there real differences? Eur J Clin Pharmacol,1999,55:85-93.
[17] Patat A,Stubbs D,Dunmore C,et al.Lack of interaction between two antihistamines,mizolastine and cetirizine,and ethanol in psychomotor and driving performance in healthy subjects.Eur J Clin Pharmacol,1995,48:143-150.
[18] Chaufour S,Caplain H,Lilienthal N,et al.Study of cardiac repolarization in healthy volunteers performed with mizolastine,a new H1-receptor antagonist.Br J Clin Pharmacol,1999,47:515-520.
[19] Chaufour S,Le Coz F,Denolle T,et al.Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers.Int J Clin Pharmacol Ther,1998,36:286-291.
[20] Delauche-Cavallier MC,Chaufour S,Guerault E,et al.QT interval monitoring during clinical studies with mizolastine,a new H1 antihista-mine.Clin Exp Allergy,1999,29(Suppl 3):206-211.
[21] Horak F,Stubner UP.Comparative tolerability of second generation antihistamines.Drug Saf,1999,20:385-401. |
